Biosimilar therapeutic agents: issues with bioequivalence and immunogenicity.
Schellekens
H
H
D016568:Drugs, Generic / Q000009:adverse effects / Q000592:standards*; D005060:Europe; D006801:Humans; D007880:Legislation, Drug; D011994:Recombinant Proteins / Q000276:immunology / Q000592:standards* / Q000627:therapeutic use; D013810:Therapeutic Equivalency
D016568:Drugs, Generic; D011994:Recombinant Proteins